Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cytoplex-MV
- Development stage
- Unknown
- Lead developer
- Anglo-French Drugs & Industries
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Cytoplex-MV is a multivitamin and multimineral dietary supplement developed and marketed by Anglo-French Drugs & Industries. Formulated as an oral tablet, it is designed to work at the cellular level to enhance energy metabolism, boost immune function, protect against oxidative stress, and support cognitive health. Cytoplex-MV is indicated for individuals with vitamin or mineral deficiencies, fatigue, poor immunity, cognitive-support needs, dry eye, and poor night vision. It is particularly recommended for stressed-out working professionals, senior citizens, students, diabetic patients, post-menopausal women, and patients in convalescence.
- Brand names
- Cytoplex-MV
- Other names
- Cytoplex-MV Tablets
Beyond the preview
Go deeper on Cytoplex-MV.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytoplex-MV.